Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 15, 2020Endocrine ReviewsOpen Access

Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications

View Full Paper
Ask AI
Bookmark
Share

Authors

Daniel J. Drucker
Daniel J. DruckerUniversity of Toronto

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Daniel J. Drucker (2020) studied this question.

synapsesocial.com/papers/6a85ba03a46f793aa75e3bb3https://doi.org/10.1210/endrev/bnaa011
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Longer term safety of dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta‐analysis2012 · 171 citations
  2. 2Modulation of Hematopoietic Chemokine Effects In Vitro and In Vivo by DPP-4/CD262016 · 43 citations
  3. 3A Human Homolog of Angiotensin-converting Enzyme2000 · 2,047 citations
  4. 4Glucagon-Like Peptide-1 (GLP-1) Reduces Mortality and Improves Lung Function in a Model of Experimental Obstructive Lung Disease in Female Mice2013 · 135 citations
  5. 5Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection2019 · 386 citations